Addus HomeCare Co. (NASDAQ:ADUS) Receives $127.57 Consensus Price Target from Analysts

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have earned an average rating of “Moderate Buy” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and seven have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $128.29.

A number of brokerages recently commented on ADUS. Stephens restated an “overweight” rating and set a $138.00 price objective on shares of Addus HomeCare in a report on Tuesday, August 6th. TD Cowen boosted their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Royal Bank of Canada restated an “outperform” rating and issued a $141.00 target price on shares of Addus HomeCare in a research note on Tuesday, September 3rd. Finally, Macquarie initiated coverage on shares of Addus HomeCare in a research note on Friday, June 28th. They set an “outperform” rating and a $136.00 price target for the company.

Insiders Place Their Bets

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the transaction, the director now directly owns 3,866 shares of the company’s stock, valued at $502,695.98. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The disclosure for this sale can be found here. Over the last three months, insiders have sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Addus HomeCare

Several hedge funds and other institutional investors have recently modified their holdings of ADUS. Charles Schwab Investment Management Inc. lifted its position in Addus HomeCare by 7.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 179,635 shares of the company’s stock worth $16,679,000 after acquiring an additional 12,392 shares during the last quarter. Principal Securities Inc. acquired a new stake in Addus HomeCare during the 4th quarter worth approximately $26,000. Dimensional Fund Advisors LP boosted its stake in Addus HomeCare by 0.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 698,498 shares of the company’s stock valued at $64,857,000 after purchasing an additional 5,654 shares during the period. Envestnet Portfolio Solutions Inc. acquired a new position in Addus HomeCare in the 4th quarter valued at $214,000. Finally, Trexquant Investment LP bought a new position in Addus HomeCare during the 4th quarter worth $271,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 0.7 %

NASDAQ:ADUS opened at $130.95 on Monday. Addus HomeCare has a 1 year low of $78.35 and a 1 year high of $136.12. The stock has a 50-day moving average price of $128.25 and a two-hundred day moving average price of $115.42. The stock has a market cap of $2.37 billion, a price-to-earnings ratio of 32.49, a PEG ratio of 2.40 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The business had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. During the same period in the prior year, the business earned $0.94 EPS. Addus HomeCare’s revenue for the quarter was up 10.4% compared to the same quarter last year. Sell-side analysts forecast that Addus HomeCare will post 4.58 earnings per share for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.